Bone Biologics prices $7.9M public offering, uplists to Nasdaq, effects 1-for-2.5 reverse split

Bone Biologics Corp

Offering of 1,510,455 units at $5.25/unit raised $7.9M gross; units consist of 1 share + 1 warrant (strike $6.30, 5-year term).
Common stock and warrants began trading on Nasdaq Capital Market Oct 13 under symbols BBLG and BBLGW.
Company effected 1-for-2.5 reverse stock split effective Oct 12, 2021.
Underwriters granted 45-day over-allotment option for up to 226,568 additional shares and/or warrants.
WallachBeth Capital acted as sole book-running manager; closing expected Oct 15, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.